share_log

Shandong Jincheng Pharmaceutical Group: The subsidiary has obtained the drug registration certificate for Posaconazole enteric-coated tablets and injectable cefoperazone sodium.

Breakings ·  Jun 5 02:43

Shandong Jincheng Pharmaceutical Group announced that its subsidiary Peking Jincheng Taier Pharmaceutical Co., Ltd. and its holding subsidiary Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. have respectively received the "Drug Registration Certificate" issued by the National Medical Products Administration. Posaconazole enteric-coated tablets are a second-generation triazole antifungal agent used to treat invasive aspergillosis and to prevent invasive aspergillosis and Candida infections.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment